Projects per year
Organization profile
Organization profile
The Hormel Institute’s vision is specific: Improve the health of the world The Hormel Institute remains focused on the vision it has had since its beginning in 1942…to help humanity by improving health through scientific research. In sixty-five years of medical research, The Hormel Institute has made significant discoveries that have advanced the health potential for people globally. The Hormel Institute is a world-recognized leader in the scientific field showing that dietary factors prevent and control cancer development. The institute is accelerating cancer research discoveries to achieve its mission: Improve your health and well-being.
Fingerprint Dive into the research topics where Hormel Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Neoplasms
Medicine & Life Sciences
Transcription Factor AP-1
Medicine & Life Sciences
Phosphorylation
Medicine & Life Sciences
Carcinogenesis
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Growth
Medicine & Life Sciences
Phosphotransferases
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1992 2023
Combating lung cancer resistance to EGFR targeted therapy
Hoeppner, L. H., Aslanidi, G. & Yang, R.
1/1/20 → 12/31/20
Project: Research project
Lung Neoplasms
Therapeutics
Integrative analysis of exitrons in metastatic prostate cancer
9/15/19 → 9/14/22
Project: Research project
Prostatic Neoplasms
Direct genome-wide detection of carcinogen-induced alkyl DNA adducts by Single Molecule Real Time Sequencing
NIH NATL INST OF ENVIRON HEALTH SCIENCES
7/1/19 → 5/31/20
Project: Research project
DNA Adducts
Carcinogens
Genes
Molecules
Research Output 1977 2019
(S)-10-hydroxycamptothecin inhibits esophageal squamous cell carcinoma growth in vitro and in vivo via decreasing topoisomerase i enzyme activity
Song, M., Yin, S., Zhao, R., Liu, K., Kundu, J. K., Shim, J. H., Lee, M. H. & Dong, Z., Dec 2019, In : Cancers. 11, 12, 1964.Research output: Contribution to journal › Article
Open Access
Type I DNA Topoisomerase
Enzymes
Growth
Cell Cycle
Neoplasms
3,3’-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2
Tian, X., Liu, K. D., Zu, X., Ma, F., Li, Z., Lee, M. H., Chen, H., Li, Y., Zhao, Y., Liu, F., Oi, N., Bode, A. M., Dong, Z. & Kim, D. J., Apr 28 2019, In : Cancer Letters. 448, p. 20-30 11 p.Research output: Contribution to journal › Article
Heterografts
Colon
Growth
Neoplasms
Colonic Neoplasms
14
Citations
(Scopus)
AKt as a therapeutic target for cancer
Song, M., Bode, A. M., Dong, Z. & Lee, M. H., Jan 1 2019, In : Cancer Research. 79, 6, p. 1019-1031 13 p.Research output: Contribution to journal › Review article
Phosphatidylinositol 3-Kinases
Neoplasms
Phosphotransferases
Glycogen Synthase Kinases
Thymoma